News

Charles River Labs Stock (CRL) Crashes 28% as FDA Signals End of Animal Testing Era
Shares of Charles River Labs (CRL) crashed 28% after the U.S. FDA (Food and Drug Administration) announced plans to phase out the need for ...
FDA reducing animal testing presents overhang for Charles River, says TD Cowen
TD Cowen analyst Charles Rhyee reiterated a Hold rating and $179 price target on Charles River (CRL), saying the firm expects the FDA’s plan to ...